Skip to content

Public FDA record

Z-0879-05: Perkin ELmer Life and Analytical Sciences -NeoGram Amino Acids and Acylcarnitines Tandem Mass Spectrometr

Recall record Z-0879-05 for Perkin Elmer Life And Analytical. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0879-05
Company in FDA record
Perkin Elmer Life And Analytical
FDA classification date
Jun 9, 2005
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Pump failure may effect data integrity

Source facts

Action
Perkin Elmer notified US Customers by letter on 3/11/05. Instructions were provided to service engineers for preventative maintenance. During the week of 5/5/05, the firm is issuing a recall letter recalling the solvents and solutions of these kits. The firm will send a Service Engineer to oversee destruction and maintenance of the pump.
Initiated
2005-03-11
Root cause
Other
Terminated
2005-11-21
Distribution
AL, CA, CT, FL, IN, LA, GA, MI, MO, NJ, OR,SC
Recall number
Z-0879-05
Recall status
Terminated
CDRH record ID
38370
FDA classified
2005-06-09
Recall event number
31703

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗